Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Qualcomm has acquired the generative AI division of VinAI, an AI research company headquartered in Hanoi, for an undisclosed ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...

Singapore researchers are using Google DeepMind’s AlphaFold to understand the intricate protein interactions at play in ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.